Key Points
Deep clonal responses to chemotherapy are associated with improved renal and overall outcomes in patients with light chain deposition disease. Deep clonal responses should be targeted, even in patients with advanced chronic kidney disease from light chain deposition disease.
The discovery that bradyarrhythmias heralded terminal cardiac decompensation in most patients with severe cardiac AL amyloidosis supports a study of prophylactic pacemaker insertion in this patient population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.